Value proposition

What you breath reveals

We develop innovative solutions based on the analysis of exhaled biomarkers as useful tools for the diagnosis, prognosis, and monitoring of various respiratory diseases, among which asthma stands out. We currently have the evernoa BASE device, which allows to measure airway inflammation by detecting Nitric Oxide through a simple and non-invasive test.

I+D, Biomarcadores exhalados, Óxido Nítrico, Fabricación, Comercialización, ISO13485, Dispositivos Médicos, Patentes, eHealth, R&D, Exhaled Biomarkers, Nitric Oxide, Manufacturing, Commercialization, Medical Devices, Patents, FeNO, and Asthma diagnostic and management